GLP-1 Prior Authorization: What Clinic Teams Need in 2026
A practical 2026 guide to GLP-1 prior authorization requirements by payer and PBM. Covers Wegovy, Zepbound, and Mounjaro workflows, recurring payer questions, denial patterns, turnaround times, and a clinic-ready submission checklist.
Case Study: Automating High-Volume Pharma Prior Authorization
Our client, a leading digital weight-loss clinic, faced a critical operational bottleneck: their rapid growth was outpacing their ability to process medication approvals. With 100,000+ GLP-1 prescriptions annually (e.g., Wegovy, Ozempic), they relied on a team of 50 coordinators spending 20–30 minutes per case manually typing data into payer portals.
We deployed an end-to-end automated Prior Authorization (PA) pipeline that reduced the dedicated team to just 6 coordinators while maintaining a 95% automation rate. The system slashed processing time to under 1 minute for most cases and enabled real-time status synchronization, transforming a multi-day manual slog into an instant background process.

